Synovus Financial Corp stock hits 52-week high at 60.25 USD

Published 22/07/2025, 19:06
Synovus Financial Corp stock hits 52-week high at 60.25 USD

Synovus (NYSE:SNV) Financial Corp stock reached a 52-week high of 60.25 USD, marking a significant milestone for the $8.07 billion market cap financial services company. According to InvestingPro data, the stock currently trades at an attractive P/E ratio of 10.6x while maintaining a steady dividend yield of 2.81%. This achievement reflects a notable upward trend, with the stock delivering a 25% return over the past year. The surge to this new high underscores investor confidence, supported by 14 analysts recently revising their earnings estimates upward. InvestingPro analysis reveals the company has maintained dividend payments for an impressive 52 consecutive years, demonstrating long-term financial stability. As Synovus continues to navigate the market landscape, this 52-week high serves as a testament to its strategic initiatives and operational efficiency. Analyst targets suggest further potential upside, with price targets ranging from $55 to $70 per share. For deeper insights and additional ProTips, explore the comprehensive research available on InvestingPro.

In other recent news, Synovus Financial is considering strategic options, including a potential merger, after attracting interest from other parties. The bank has engaged a financial adviser and conducted merger discussions with at least one competitor. Synovus Financial’s second-quarter results have led to several analyst upgrades and increased price targets. Raymond (NSE:RYMD) James upgraded the stock from Market Perform to Outperform, citing results that exceeded forecasts and consensus estimates. Keefe, Bruyette & Woods also upgraded the stock to Outperform, noting better-than-expected performance in fees and loan loss provisions. DA Davidson raised its price target to $63, driven by the bank’s strong second-quarter performance and an improved earnings outlook for 2025. Citi raised its price target to $65, highlighting Synovus’s robust quarterly loan growth. These developments reflect a positive outlook for the bank’s financial health and growth potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.